Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Single-vial Taxotere formulation launched in Japan

July 21, 2011

First patient enrolled in NCI's pediatric phase I trial of Marqibo

July 21, 2011

Taiho and Nordic Group to collaborate on Teysuno

July 21, 2011

Chinese university presents new antitumor noscapine derivatives

July 21, 2011

New irreversible epidermal growth factor receptor inhibitor shows preclinical antitumor activity

July 21, 2011

Halaven launched in Japan for inoperable/recurrent breast cancer

July 19, 2011

Talon Therapeutics submits NDA for Marqibo to FDA

July 19, 2011

Cyclacel and Daiichi Sankyo amend sapacitabine licensing agreement

July 19, 2011

COMP recommends orphan drug status for Nektar Therapeutics' lead oncology agent in ovarian cancer

July 19, 2011

Merck & Co.'s new frizzled SMO receptor antagonist MK-5710 has antitumor activity in vivo

July 19, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...